DOXYCHEL HYCLATE Drug Patent Profile
✉ Email this page to a colleague
When do Doxychel Hyclate patents expire, and what generic alternatives are available?
Doxychel Hyclate is a drug marketed by Rachelle and is included in one NDA.
The generic ingredient in DOXYCHEL HYCLATE is doxycycline hyclate. There are twenty-eight drug master file entries for this compound. Seventy-four suppliers are listed for this compound. Additional details are available on the doxycycline hyclate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Doxychel Hyclate
A generic version of DOXYCHEL HYCLATE was approved as doxycycline hyclate by CARIBE HOLDINGS on November 8th, 1982.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DOXYCHEL HYCLATE?
- What are the global sales for DOXYCHEL HYCLATE?
- What is Average Wholesale Price for DOXYCHEL HYCLATE?
Summary for DOXYCHEL HYCLATE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 55 |
Patent Applications: | 438 |
DailyMed Link: | DOXYCHEL HYCLATE at DailyMed |
US Patents and Regulatory Information for DOXYCHEL HYCLATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Rachelle | DOXYCHEL HYCLATE | doxycycline hyclate | INJECTABLE;INJECTION | 061953-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |